Screening for Angiotensin 1-Converting Enzyme Inhibitory Activity of Ecklonia cava

  • Athukorala Yasantha (Faculty of Applied Marine Science, Cheju National University) ;
  • Jeon, You-Jin (Faculty of Applied Marine Science, Cheju National University)
  • Published : 2005.06.01


Seven brown algal species (Ecklonia cava, Ishige okamurae, Sargassum fulvellum, Sargassum horneri, Sargassum coreanum, Sargassum thunbergii and Scytosiphon lomentaria) were hydrolyzed using five proteases (Protamex, Kojizyme, Neutrase, Flavourzyme and Alcalase) and screened for angiotensin 1-converting enzyme (ACE) inhibitory activities. Most algal species examined showed good ACE inhibitory activities after the enzymatic hydrolysis. However, E. cava was the most potent ACE inhibitor of the seven species. Flavourzyme digest of E. cava exhibited an $IC_{50}$ of around $0.3\;{\mu}g/mL$ for ACE; captopril has an $IC_{50}$ of $\~0.05\;{\mu}g/mL$. The Flavourzyme digest was separated to three fractions by an ultrafiltration membrane (5, 10, 30 kDa MWCO) system according to the molecular weights. The active components were mainly concentrated in >30 kD fraction which are composed of the highest protein content $(27\%)$ and phenolic content (261 mg/100 mL) compared to the other two smaller molecular weight fractions. Therefore, the active compounds appear to be relatively high molecular weight complex molecules associated with protein (glycoprotein) and polyphenols. Therefore, E. cave is a potential source of antihypertensive compound.


brown algae;Ecklonia cava;ACE inhibition;enzymatic hydrolysis;Flavourzyme


  1. Kohama Y, Oka H, Kayamori Y, Tsujikawa K, Mimura T, Nagase Y, Satake M. 1991. Potent synthetic analogues of angiotensin-converting enzyme inhibitor derived from tuna muscle. Agric Biol Chem 55: 2169-2170
  2. Suetsuna K. 1992. Study on the inhibitory activities against angiotensin I-converting enzyme of the peptides derived from sardine muscle. PhD Dissertation. Tokoku University, Miyagi, Sendai, Japan. p 1-92
  3. Isono Y. 1996. Peptide inhibitors for angiotensin I-converting enzyme from Masai fermented milk. Food Sci Technol Int 2: 213-216
  4. Kato H, Suzuki T. 1971. Bradykinin-potentiating peptides from the venom of Agkistrodon halys blomhoffii: Isolation of five bradykinin potentiators Band C. Biochem 10: 972-980
  5. Sawayama T, Itokawa A, Shimada K, Doi Y, Kimura K, Nishimura H. 1990. Synthesis of 1-[(s)-3-acetylthio-2-methylpropanoyl]-L-propyl-L-phenylalanine (Alacepril) and one of its active metabolites, the desacetyl derivative (DU-1227). Chem Pharm Bull 38: 529-531.
  6. Ondetti MA. 1977. Design of specific inhibitors of angiotensinconverting enzyme: New class of orally active antihypertensive agents. Science 196: 441-444
  7. Atkinson AB, Robertson JIS. 1979. Captopril in the treatment of clinical hypertension and cardiac failure. Lancet 2: 836-839
  8. Maruyama S, Mitachi H, Awaya J. 1987. Angiotensin I-converting enzyme inhibitory activity of the c-terminal hexapeptide of as l-casein. Agric Biol Chem 51: 2557-2561
  9. Kohmura M, Nio N, Kubo K. 1989. Inhibition of angiotensin-converting enzyme by synthetic peptides of humancasein. Agric Biol Chem 53: 2107-2114
  10. Miyoshi S, Ishikawa I, Kaneko T, Fukui F, Tanaka H, Maruyama S. 1991. Structures and activity of angiotensinconverting enzyme inhibitors in an $\alpha$ -zein hydrolysate. Agric Biol Chem 55: 1313-1318
  11. Yano S, Suzuki K, Funatsu G. 1996. Isolation from alphazein of thermolysin peptides with angiotensin I-converting enzyme inhibitory activity. Biosci Biotech Biochem 60: 661-663
  12. Chen JR, Okada T, Muramoto K. 2002. Identification of angiotensin I-converting enzyme inhibitory peptides derived from the peptic digest of soybean protein. J Food Biochem 6: 543-544
  13. Astawan M, Wahyuni M, Yasuhara T. 1995. Effects of angiotensin I-converting enzyme inhibitory substances derived from Indonesian dried-salted fish on blood pressure of rats. Biosci Biotech Biochem 59: 524-529
  14. Fujita H, Sasaki R, Yoshikawa M. 1995. Potentiation of the antihypertensive activity of orally administered ovokinin, a vasorelaxing peptide derived from ovalbumin, by emulsification in egg phosphatidylcholine. Biosci Biotech Biochem 59: 2344-2345
  15. Okamoto A, Matsumoto E, Iwashita A. 1995. Angiotensin I-converting enzyme inhibitory action of fish sauce. Food Sci Technol Int 1: 101-106
  16. Wako Y, Abe Y, Handa T, Ishikawa S. 1999. Angiotensin I-converting enzyme inhibitors in fish water soluble protein hydrolyzates prepared by bioreactor. Food Sci Technol Res 5: 378-380
  17. Suetsuna K. 1998. Purification and identification of angiotensin l-converting enzyme inhibitors from the red alga Porphyra yezoensis. J Mar Biotech 6: 163-167
  18. Lowry OH, Rosebrough NJ, Farr L, Rindall RJ. 1951. Protein mesurement with the folin phenol reagent. J Biol Chem 193: 256-259
  19. Cushman DW, Chung HS. 1970. Spectrometric assay and properties of the angitensin I-converting enzyme of rabbit lung. Biochem Pharmaco 20: 1637-1684
  20. Chandler SF, Dodds JH. 1993. The effect of phosphate, nitrogen and sucrose on the production phenolics and solasidine in callus cultures of Solanum laciniatum. Plant Cell Rep 2: 105-110
  21. Adler-Nissen J. 1979. Determination of the degree of hydrolysis of food protein hydrolysates by trinitrobenzenesulfonic acid. J Agric Food Chem 27: 1256-1262
  22. Mahmoud MI, Malone WT, Cordle CT. 1992. Enzymatic hydrolysis of casein: effect of degree of hydrolysis on antigenicity and physical properties. J Food Sci 57: 1223-1229
  23. Watanabe T, Mazumder TK, Nagai S, Tsuji K, Terabe S. 2003. Analysis method of the angiotensin-I converting enzyme inhibitory activity based on micellar electrokinetic chromatography. Anal Sci 19: 159-161
  24. Paulis JW, Bietz JA. 1986. Separation of alcohol soluble maize proteins by reversed phase high performance liquid chromatography. J Cereal Sci 4: 205-211
  25. Liu JC, Hsu FL, Tsai JC, Chan P, Liu JYH, Thomas GN, Tomlinson B, Lo MY, Lin JY. 2003. Antihypertensive effects of tannins isolated from traditional Chinese herbs as non-specific inhibitors of angiotensin converting enzyme. Life Sci 73: 1543-1555
  26. Rojas A, Bah M, Rojas JI, Gutierrez DM. 2000. Smooth muscle relaxing activity of gentiopicroside isolated from Gentiana spathacea. Planta Med 66: 765-767
  27. Black HR, Ming S, Poll DS, Wen YF, Zhou HY, Zhang ZQ, Chung YK, Wu YS. 1986. A comparison of the treatment of hypertension with Chinese herbal and Western medication. J Clin Hypertens 24: 371-378
  28. Mao HY, Tu YS, Nei FD, Liang GF, Feng YB. 1981. Rapid antihypertensive effect of rhomotoxin in 105 hypertension cases. Chinese Med J 94: 733-736
  29. Pihlanto-Leppala A. 2001. Bioactive peptides derived from bovine whey proteins: opioid and ace-inhibitory peptides. Trends Food Sci Technol 11: 347-356
  30. Kim JM, Whang JH, Suh HJ. 2004. Enhancement of angitensin l-converting enzyme inhibitory activity and improvement of the emulsifying and foaming properties of com glutein hydrolysate using ultrafiltration membranes. Eur Food Res Technol 218: 133-138
  31. Suetsuna K, Nakano T. 2000. Identification of an antihypertensive peptide frompeptic digest of wakame (Undaria pinnatifida). J Nutr Biochem 11: 450-454
  32. Choi HS, Cho HY, Yang HC, Ra KS, Suh HI. 2001. Angiotensin l-converting enzyme inhibitor from Grifola frondosa. Food Res Int 34: 117-182

Cited by

  1. Radical scavenging capacity and cytoprotective effect of enzymatic digests of Ishige okamurae vol.20, pp.6, 2008,
  2. Antioxidant activity and cell protective effect of loliolide isolated from Sargassum ringgoldianum subsp. coreanum vol.26, pp.2, 2011,
  3. Hepatoprotective effects of dieckol-rich phlorotannins from Ecklonia cava, a brown seaweed, against ethanol induced liver damage in BALB/c mice vol.50, pp.6, 2012,
  4. Phlorotannins as bioactive agents from brown algae vol.46, pp.12, 2011,
  5. Protective Effect of Enzymatic Extracts from Sargassum coreanum on H2O2-induced Cell Damage vol.13, pp.1, 2010,
  6. Antioxidant Effect of Sargassum coreanum Root and Stem Extracts vol.30, pp.4, 2015,
  7. Phlorotannins from Ecklonia cava (Phaeophyceae): Biological activities and potential health benefits vol.36, pp.6, 2010,
  8. Characterisation of a new antihypertensive angiotensin I-converting enzyme inhibitory peptide from Pleurotus cornucopiae vol.127, pp.2, 2011,
  9. Thermostability of a marine polyphenolic antioxidant dieckol, derived from the brown seaweed Ecklonia cava vol.27, pp.3, 2012,
  10. Effect of phlorotannins isolated fromEcklonia cavaon angiotensin I-converting enzyme (ACE) inhibitory activity vol.5, pp.2, 2011,
  11. ACE, α-Glucosidase and Cancer Cell Growth Inhibitory Activities of Extracts and Fractions from Marine Microalgae, Nannochloropsis oculata vol.43, pp.5, 2010,
  12. Enzyme-assisted extraction of κ/ι-hybrid carrageenan from Mastocarpus stellatus for obtaining bioactive ingredients and their application for edible active film development vol.5, pp.2, 2014,
  13. Screening of Extracts from Red Algae in Jeju for Potentials MarineAngiotensin - I Converting Enzyme (ACE) Inhibitory Activity vol.21, pp.3, 2006,
  14. Dieckol isolated from brown seaweed Ecklonia cava attenuates type ІІ diabetes in db/db mouse model vol.53, 2013,
  15. Exploiting biological activities of brown seaweedEcklonia cavafor potential industrial applications: a review vol.63, pp.2, 2012,
  16. Antihypertensive Angiotensin I-Converting Enzyme Inhibitory Activity and Antioxidant Activity ofVitishybrid-Vitis coignetiaeRed Wine Made withSaccharomyces cerevisiae vol.39, pp.2, 2011,
  17. Evaluation of Angiotensin -I- Converting Enzyme Inhibitory Activity and Protein Changes of Enzymatic Hydrolysate Extracted from Hanwoo Loin and Round Myosin B vol.49, pp.1, 2007,
  18. Radical Scavenging Potential of Hydrophilic Phlorotannins of Hizikia fusiformis vol.20, pp.1, 2005,
  19. Enzyme-assisted extraction of cactus bioactive molecules under high hydrostatic pressure vol.94, pp.5, 2014,
  20. Microalgal lipids biochemistry and biotechnological perspectives vol.32, pp.8, 2014,
  21. Effects of dietary supplementation with citrus pomace and Ecklonia cava residue on the physiological changes and growth of disk abalone, Haliotis discus discus vol.28, pp.1, 2015,
  22. A Molecular Sex Identification Using Duplex PCR Method for SRY and ZFX-ZFY Genes in Red Deer and Elk vol.49, pp.1, 2007,
  23. Comparison of biological activities in Sargassum siliquanstrum fermented by isolated lactic acid bacteria vol.20, pp.2, 2015,
  24. Enzyme proteolysis enhanced extraction of ACE inhibitory and antioxidant compounds (peptides and polyphenols) from Porphyra columbina residual cake vol.25, pp.4, 2013,
  25. Angiotensin-converting enzyme I inhibitory activity of phlorotannins from Ecklonia stolonifera vol.72, pp.6, 2006,
  26. Hypoglycemic Effect of Sargassum ringgoldianum Extract in STZ-induced Diabetic Mice vol.17, pp.1, 2012,
  27. Protective effect of fucoidan against AAPH-induced oxidative stress in zebrafish model vol.102, 2014,
  28. Protective effect of Ecklonia cava on UVB-induced oxidative stress: in vitro and in vivo zebrafish model vol.23, pp.4, 2011,
  29. Potential pharmacological applications of polyphenolic derivatives from marine brown algae vol.32, pp.3, 2011,
  30. Biological Properties of Fucoxanthin in Oil Recovered from Two Brown Seaweeds Using Supercritical CO2 Extraction vol.13, pp.6, 2015,
  31. Angiotensin-I-Converting Enzyme (ACE) Inhibitors from Marine Resources: Prospects in the Pharmaceutical Industry vol.8, pp.4, 2010,
  32. Bio-functionalities of proteins derived from marine algae — A review vol.48, pp.2, 2012,
  33. Processing Optimization of Ecklonia cava Extract-Added Seasoning Sauce for Instant Noodles vol.44, pp.3, 2011,
  34. Improvement on the Antioxidant Activity of Instant Noodles Containing Enzymatic Extracts from Ecklonia cava and Its Quality Characterization vol.43, pp.5, 2010,
  35. Antioxidant Activity of Enzymatic Extracts from Sargassum coreanum vol.39, pp.4, 2010,
  36. Angiotensin I-Converting Enzyme (ACE) Inhibitory Activity, Antioxidant Properties, Phenolic Content and Amino Acid Profiles of Fucus spiralis L. Protein Hydrolysate Fractions vol.15, pp.10, 2017,
  37. Extract Attenuates Palmitate-Induced Toxicity and Enhances Insulin Secretion in Pancreatic Beta-Cells vol.2018, pp.1942-0994, 2018,
  38. Potential Role of Seaweed Polyphenols in Cardiovascular-Associated Disorders vol.16, pp.8, 2018,
  39. elucidation of angiotensin-I-converting enzyme inhibition and antioxidant potential vol.21, pp.1, 2018,
  40. Dual BACE1 and Cholinesterase Inhibitory Effects of Phlorotannins from Ecklonia cava—An In Vitro and in Silico Study vol.17, pp.2, 2019,